Efficacy of Osmotic-Release Oral System (OROS) Methylphenidate for Mothers With Attention-Deficit/Hyperactivity Disorder (ADHD): Preliminary Report of Effects on ADHD Symptoms and Parenting.

Authors :: Chronis-Tuscano, Andrea
Seymour, Karen E.
Stein, Mark A.
Jones, Heather A.
Jiles, Cynthia D.
Rooney, Mary E.
Conlon, Charles J.
Efron, Lisa A.
Wagner, Stephanie A.
Pian, Jessica
Robb, Adelaide S.
Source :: Journal of Clinical Psychiatry; Dec2008, Vol. 69 Issue 12, p1938-1947, 10p, 1 Diagram, 5 Charts
Publication Year :: 2008
Abstract: The article details a study which examined the effectiveness of osmotic-release oral system (OROS) methylphenidate in treating attention-deficit/hyperactivity disorder (ADHD) symptoms and parenting behaviors in mothers. The study included 23 mother-child dyads in which both were diagnosed with ADHD. It found that mothers well tolerated OROS methylphenidate. Study authors concluded that OROS methylphenidate causes significant improvement in maternal ADHD symptoms and parenting.

Subjects :: METHYLPHENIDATE
ATTENTION-deficit hyperactivity disorder
PSYCHOLOGY of mothers
MATERNAL health services
DRUG efficacy
CLINICAL drug trials

Full Text Access

Tools